Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hattis

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 1, 1990
Pharmacokinetic principles for dose-rate extrapolation of carcinogenic risk from genetically active agentsD Hattis
Environmental Health Perspectives|January 1, 1991
Use of biological markers and pharmacokinetics in human health risk assessmentD Hattis
Environmental Health Perspectives|April 1, 1996
The challenge of mechanism-based modeling in risk assessment for neurobehavioral end pointsD Hattis
Environmental Health Perspectives|October 1, 1981
Needs for public health intervention and needs for new research on vinyl halides and their polymers: a public policy perspectiveD Hattis
Toxicology|July 17, 1996
Human interindividual variability in susceptibility to toxic effects: from annoying detail to a central determinant of riskD Hattis
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1994
The importance of exposure measurements in risk assessment of drugsD Hattis
Environmental Toxicology and Pharmacology|July 26, 2011
Variability in susceptibility - how big, how often, for what responses to what agents?D Hattis
Environmental Toxicology and Pharmacology|July 26, 2011
Human variability in susceptibility How big, how often, for what responses to what agents?D Hattis
Environmental Geochemistry and Health|November 8, 2013
The use of well-defined biomarkers (such as blood lead) in risk assessmentD Hattis
Science (New York, N.Y.)|October 10, 1986
Pharmacogenetics: ethnic differences in reactions to drugs and xenobioticsD Hattis
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 1, 1990
Pharmacokinetic principles for dose-rate extrapolation of carcinogenic risk from genetically active agentsD Hattis
Environmental Health Perspectives|January 1, 1991
Use of biological markers and pharmacokinetics in human health risk assessmentD Hattis
Environmental Health Perspectives|April 1, 1996
The challenge of mechanism-based modeling in risk assessment for neurobehavioral end pointsD Hattis
Environmental Health Perspectives|October 1, 1981
Needs for public health intervention and needs for new research on vinyl halides and their polymers: a public policy perspectiveD Hattis
Toxicology|July 17, 1996
Human interindividual variability in susceptibility to toxic effects: from annoying detail to a central determinant of riskD Hattis
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1994
The importance of exposure measurements in risk assessment of drugsD Hattis
Environmental Toxicology and Pharmacology|July 26, 2011
Variability in susceptibility - how big, how often, for what responses to what agents?D Hattis
Environmental Toxicology and Pharmacology|July 26, 2011
Human variability in susceptibility How big, how often, for what responses to what agents?D Hattis
Environmental Geochemistry and Health|November 8, 2013
The use of well-defined biomarkers (such as blood lead) in risk assessmentD Hattis
Science (New York, N.Y.)|October 10, 1986
Pharmacogenetics: ethnic differences in reactions to drugs and xenobioticsD Hattis
Pageof 4